Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2006-11-07
2006-11-07
Padmanabhan, Sreenivasan (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C554S117000, C549S422000
Reexamination Certificate
active
07132453
ABSTRACT:
The present invention discloses methods and a kit for treating a respiratory syncytial virus infection. The method comprises providing an infection modulator, and administering a therapeutically effective amount of the infection modulator, wherein the respiratory syncytial virus infection is suppressed or precluded. The kit for suppressing a respiratory syncytial virus infection comprises an infection modulator, an applicator, and a set of instructions.
REFERENCES:
patent: 2001/0044467 (2001-11-01), Neal
patent: 0671410 (1990-07-01), None
patent: 2 166 050 (1986-04-01), None
Miyamori et al, 95CA:109278, 1984.
Zavagno, et al.,Role of Prostaglandins and Non-steroid Anti-inflammatory Drugs in the Pathogenicity of Vaccinia Virus, Journal of General Virology (1987) 68:593-600. SGM, Great Britain (The year of publication is sufficiently earlier than the effective U.S. filing date and any foreign priority date so that the particular month of publication is not in issue).
Patterson, J.H., et al.,Acute Hemodynamic Effects of the Prostacyclin Analog 15AU81 in Severe Congestive Heart Failure, American Journal of Cardiology (Jan. 1995) 75:26A-33A, Excerpta Medica, USA. (ABSTRACT only).
Belch, J.J., et al.,Oral Iloprost As a Treatment for Raynaud's Syndrome: A Double Blind Multicentre Placebo Controlled Study, Annals of Rheumatic Diseases (Mar. 1995) 54:197-2000, BMJ Publishing Group, UK.. (ABSTRACT only).
Saji, et al.,Short-Term Hemodynamic Effect of a New Oral PGI2 Analogue, Beraprost, in Primary and Secondary Pulmonary Hypertension, American Journal of Cardiology (Jul. 1996) 78:244-247, Excerpta Medica, Inc., USA.
Higenbottam, et al.,Treatment of Pulmonary Hypertension with the Continuous Infusion of a Prostacyclin Analogue, Iloprost, Heart (1998) 79:175-179, BMJ Publishing Group, UK (The year of publication is sufficiently earlier than the effective U.S. filing date and any foreign priority date so that the particular month of publication is not is issue).
Higenbottam, et al.,Long Term Intravenous Prostaglandin(epoprostenol or Iloprost)for treatment of Severe Pulmonary Hypertension, Heart (1998) 80:151-155, BMJ Publishing Group, UK (The year of publication is sufficiently earlier than the effective U.S. filing date and any foreign priority date so that the particular month of publication is not in issue).
Fink, et al.,Use of Prostacyclin and its Analogues in the Treatment of Cardiovascular Disease, Heart Disease (1999) 1:29-40, Lippincott Williams & Wilkins, Inc., USA (The year of publication is sufficiently earlier than the effective U.S. filing date and any foreign priority date so that the particular month of publication is not in issue).
Gaine, et al.,Acute Hemodynamic Effects of Subcutaneous UT-15 in Primary Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine (Mar. 1999) 159:A161, American Thoracic Society, USA.
Nagaya,Effect of Orally Active Prostacyclin Analogue on Survival of Outpatients With Primary Pulmonary Hypertension, Journal of the American College of Cardiology (Oct. 1999) 34:1188-1192, Elsevier Science, Inc. USA.
Olschewski, et al.,Inhales Iloprost to Treat Severe Pulmonary Hypertension, Annals of Internal Medicine (Mar. 2000) 132:435-443, American College of Physicians—American Society of Medicine, USA.
Max et al, “Inhaled prostacyclin in the treatment of pulmonary hyerptension”, European Journal of Pediatrics 1999 vol. 158 (suppl. J), s23-s26, CAPLUS Abstract AN, 1999:809374.
Graham Barney S.
Hashimoto Koichi
Peebles, Jr. Ray Stokes
Padmanabhan Sreenivasan
Vanderbilt University
Williams Leonard
Wyatt Tarrant & Combs LLP
LandOfFree
Method of using prostacyclin to treat respiratory syncytial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of using prostacyclin to treat respiratory syncytial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using prostacyclin to treat respiratory syncytial... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3632541